CS logo
small CS logo
Malopolskie Centrum Kliniczne

Krakow, Poland
Medical center in Kraków
Balicka 12a/5b, 30-149 Kraków

About Malopolskie Centrum Kliniczne


"Jesteśmy Ośrodkiem Badań klinicznych specjalizującym się w prowadzeniu badań klinicznych fazy I do IV. Nasze doświadczenie to ponad dekada pracy w zakresie prowadzenia badań, podczas którego z sukcesem przeprowadziliśmy kilkadziesiąt projektów fazy I – IV . Zajmując się wyłącznie obszarem badań klinicznych jesteśmy w stanie zapewnić naszym pacjentom najwyższą jakość opieki i poziom bezpieczeństwa a naszym kontrahentom najwyższe standardy i jakość prowadzonych badań."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Pfizer
2
Mitsubishi Tanabe Pharma America Inc.
1
Regeneron Pharmaceuticals
1
Total Rows: 4

Clinical Trials at Malopolskie Centrum Kliniczne


During the past decade, Malopolskie Centrum Kliniczne conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years113300002211000000001111Started TrialsCompleted Trails20172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip
2017-08-17
2021-08-27
Completed
3,307
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
2018-04-13
2030-06-30
Active, not recruiting
1,409
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
2018-06-11
2020-10-07
Completed
1,235
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
2021-02-05
2024-02-01
Active, not recruiting
72
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
2021-09-28
2026-09-07
Recruiting
450
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
2022-01-19
2025-08-14
Recruiting
318

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Malopolskie Centrum Kliniczne" #1 collaborator was "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsJanssen Research &Development, LLC: 3Janssen Research &Development, LLC: 3Pfizer: 2Pfizer: 2Mitsubishi TanabePharma America Inc.: 1Mitsubishi TanabePharma America Inc.: 1Regeneron Pharmaceuticals: 1Regeneron Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsTeva PharmaceuticalIndustries, Ltd.: 1Teva PharmaceuticalIndustries, Ltd.: 1

Clinical Trials Conditions at Malopolskie Centrum Kliniczne


According to Clinical.Site data, the most researched conditions in "Malopolskie Centrum Kliniczne" are "Dermatitis, Atopic" (2 trials), "Arthritis, Psoriatic" (1 trials), "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "Malopolskie Centrum Kliniczne" in a lesser frequency.

Clinical Trials Intervention Types at Malopolskie Centrum Kliniczne


Most popular intervention types in "Malopolskie Centrum Kliniczne" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Malopolskie Centrum Kliniczne


The vast majority of trials in "Malopolskie Centrum Kliniczne" are 7 trials for "All" genders.

Clinical Trials Status at Malopolskie Centrum Kliniczne


Currently, there are NaN active trials in "Malopolskie Centrum Kliniczne". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Malopolskie Centrum Kliniczne, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Malopolskie Centrum Kliniczne, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 3Active, not recruiting: 3Completed: 2Completed: 2Recruiting: 2Recruiting: 2